Patient advocate, educator, and surgeon focused on improving quality of life. Board certified general surgeon with a specialization in liver, bile duct, and pancreatic surgery.
Dr. Clark is a Diplomate of the American Board of Surgery and Fellow of the American College of Surgeons. He holds a Hepatobiliary and Pancreatic (HPB) Fellowship certificate by the Fellowship Council. He is trained to perform general surgery with
Dr. Clark’s research has focused on improving outcomes after complex abdominal surgery (whipple procedure), as well as, investigating strategies to maintain or improve quality of life of patients with pancreatic disease. Dr. Clark is also active in the education of general surgery residents
Numerous health education resources are available, many of which are excellent and very informative. We provide educational resources and answers to the most common questions raised in our clinic. Most importantly, use common sense and follow your physician’s advice and recommendations.
Most Recent News, Information, Resources, and Commentary
- Real-time Location Systems Revolutionize Patient CareReal-time location systems (RTLS) can provide a novel approach to monitoring in-hospital patient activity, which can be beneficial in postoperative recovery. Our study titled “Feasibility of real-time location systems in monitoring recovery after major abdominal surgery” published in the journal
- Immunotherapy for Pancreatic CancerPancreatic cancer is a devastating disease that is often difficult to treat. Traditional treatment options, such as chemotherapy and radiation therapy, have limited success in treating this disease. However, in recent years, immunotherapy has emerged as a promising treatment option
- Keytruda (Pembrolizumab), Immunotherapy for Pancreatic CancerKeytruda, also known as Pembrolizumab, is a type of immunotherapy medication that is used to treat various types of cancer. It belongs to a class of drugs known as immune checkpoint inhibitors that work by stimulating the immune system to
- What is durvalumab?Durvalumab is an immunotherapy drug that is used to treat certain types of cancer. It belongs to a class of drugs called checkpoint inhibitors, which work by releasing the brakes on the immune system, allowing it to attack cancer cells.
- Gib Akin’s Modes of LearningGib Akin (1940-2014) was a writer on business and management, and professor emeritus at the McIntyre School of Business of the University of Virginia. He conducted qualitative interviews with 60 managers to understand how they learn. This study can help